Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Rosemont Pharmaceuticals Ltd, Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK
Perizam 2mg/ml Oral Suspension.
| Pharmaceutical Form |
|---|
|
Oral Suspension. An off-white suspension. |
Each ml of oral solution contains 2mg Clobazam.
Excipient(s) with known effect:
Sodium Methyl parahydroxybenzoate (E219) (1.32mg)
Sodium Propyl parahydroxybenzoate (E217) (0.33mg)
Liquid Maltitol (E965) (0.3g)
Propylene Glycol (E1520) (6.21mg)
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clobazam |
Clobazam is a 1,5-benzodiazepine and the pharmacodynamic activity is qualitatively similar to that of other compounds of the class of Muscle relaxant, Anxiolytic, Sedative, Hypnotic, Anticonvulsant, Amnesic. |
| List of Excipients |
|---|
|
Aluminium magnesium silicate |
Bottle: Amber (Type III glass)
Closure: HDPE, EPE wadded, child resistant closure.
Pack size: 150ml
Syringe: Polypropylene body and HDPE plunger with a capacity of 5ml.
Bottle adaptor: Low Density Polyethylene. The bottle adaptor is not pre-fitted.
Rosemont Pharmaceuticals Ltd, Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK
PL00427/0228
Date of last renewal: 26th of January 2020
| Drug | Countries | |
|---|---|---|
| PERIZAM | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
